A viral peptide that targets mitochondria protects against neuronal degeneration in models of Parkinson’s disease
暂无分享,去创建一个
D. Gonzalez-Dunia | S. Hunot | J. Peyrin | Y. Monnet | A. Thouard | Cécile A. Ferré | A. Bétourné | M. Szelechowski | C. Foret | C. Ferré | A. Betourne
[1] G. Banker,et al. Axonal transport plays a crucial role in mediating the axon-protective effects of NmNAT , 2014, Neurobiology of Disease.
[2] Sang Ki Park,et al. CDK5-dependent inhibitory phosphorylation of Drp1 during neuronal maturation , 2014, Experimental & Molecular Medicine.
[3] J. Gilley,et al. Wallerian degeneration: an emerging axon death pathway linking injury and disease , 2014 .
[4] G. Le Douaron,et al. MALDI Mass Spectrometry Imaging of 1-Methyl-4-phenylpyridinium (MPP+) in Mouse Brain , 2013, Neurotoxicity Research.
[5] M. Shamloo,et al. Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration. , 2013, The Journal of clinical investigation.
[6] J. Viovy,et al. NAD+ acts on mitochondrial SirT3 to prevent axonal caspase activation and axonal degeneration , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] N. Unsain,et al. XIAP regulates caspase activity in degenerating axons. , 2013, Cell reports.
[8] Jean-Louis Viovy,et al. Synapto-Protective Drugs Evaluation in Reconstructed Neuronal Network , 2013, PloS one.
[9] Lauren E. Marbella,et al. Observing the translocation of a mitochondria-penetrating peptide with solid-state NMR. , 2013, Biochimica et biophysica acta.
[10] J. Qian,et al. MAVS-mediated host cell defense is inhibited by Borna disease virus. , 2013, The international journal of biochemistry & cell biology.
[11] J. Ramsey,et al. Distinct Pathways Mediate Axon Degeneration during Apoptosis and Axon-Specific Pruning , 2013, Nature Communications.
[12] M. Iijima,et al. Mitochondrial dynamics in neurodegeneration. , 2013, Trends in cell biology.
[13] P. Wipf,et al. Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington's disease. , 2012, Cell reports.
[14] A. M. van der Bliek,et al. Mitochondrial Fission, Fusion, and Stress , 2012, Science.
[15] Christian Haass,et al. Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences , 2012, The EMBO journal.
[16] C. Perier,et al. Neurotoxin-based models of Parkinson's disease , 2012, Neuroscience.
[17] J. Milbrandt,et al. Mitofusin2 Mutations Disrupt Axonal Mitochondrial Positioning and Promote Axon Degeneration , 2012, The Journal of Neuroscience.
[18] E. Rugarli,et al. Mitochondrial quality control: a matter of life and death for neurons , 2012, The EMBO journal.
[19] L. Scorrano,et al. Less than perfect divorces: dysregulated mitochondrial fission and neurodegeneration , 2012, Acta Neuropathologica.
[20] R. Barker,et al. A novel neuroprotective therapy for Parkinson’s disease using a viral noncoding RNA that protects mitochondrial Complex I activity , 2012, The Journal of experimental medicine.
[21] W. Lipkin,et al. Borna disease virus - fact and fantasy. , 2011, Virus research.
[22] Bhuvan Unhelkar,et al. Strategies and Applications , 2011 .
[23] J. Milbrandt,et al. Image-based Screening Identifies Novel Roles for IκB Kinase and Glycogen Synthase Kinase 3 in Axonal Degeneration* , 2011, The Journal of Biological Chemistry.
[24] Bruce H. Morimoto,et al. A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions , 2011, Molecular and Cellular Neuroscience.
[25] S. Kelley,et al. Maximizing the therapeutic window of an antimicrobial drug by imparting mitochondrial sequestration in human cells. , 2011, Journal of the American Chemical Society.
[26] Y. Yoon,et al. High-glucose stimulation increases reactive oxygen species production through the calcium and mitogen-activated protein kinase-mediated activation of mitochondrial fission. , 2011, Antioxidants & redox signaling.
[27] R. Sobel,et al. Aberrant mitochondrial fission in neurons induced by protein kinase Cδ under oxidative stress conditions in vivo , 2011, Molecular biology of the cell.
[28] R. Burke,et al. Clinical progression in Parkinson disease and the neurobiology of axons , 2010, Annals of neurology.
[29] Jean-Louis Viovy,et al. Wallerian-Like Degeneration of Central Neurons After Synchronized and Geometrically Registered Mass Axotomy in a Three-Compartmental Microfluidic Chip , 2010, Neurotoxicity Research.
[30] M. Delepierre,et al. Attenuation of Rabies Virulence: Takeover by the Cytoplasmic Domain of Its Envelope Protein , 2010, Science Signaling.
[31] J. Gilley,et al. Endogenous Nmnat2 Is an Essential Survival Factor for Maintenance of Healthy Axons , 2010, PLoS biology.
[32] J. Chuckowree,et al. Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system , 2009, Brain Research Bulletin.
[33] S. Kelley,et al. Mitochondria‐Penetrating Peptides: Sequence Effects and Model Cargo Transport , 2009, Chembiochem : a European journal of chemical biology.
[34] S. Kelley,et al. Targeting Mitochondria with Organelle‐Specific Compounds: Strategies and Applications , 2009, Chembiochem : a European journal of chemical biology.
[35] P. Staeheli,et al. Second-site mutations in Borna disease virus overexpressing viral accessory protein X. , 2009, The Journal of general virology.
[36] E. Morselli,et al. Targeting post-mitochondrial effectors of apoptosis for neuroprotection. , 2009, Biochimica et biophysica acta.
[37] G. Bauer,et al. Protein X of Borna Disease Virus Inhibits Apoptosis and Promotes Viral Persistence in the Central Nervous Systems of Newborn-Infected Rats , 2009, Journal of Virology.
[38] N. Udupa,et al. A study of rivastigmine liposomes for delivery into the brain through intranasal route , 2008, Acta pharmaceutica.
[39] E. Morselli,et al. Viral Control of Mitochondrial Apoptosis , 2008, PLoS pathogens.
[40] T. Langer,et al. Quality control of mitochondria: protection against neurodegeneration and ageing , 2008, The EMBO journal.
[41] Ruben Abagyan,et al. Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease , 2007, Science.
[42] Toshihiko Oka,et al. Mitotic Phosphorylation of Dynamin-related GTPase Drp1 Participates in Mitochondrial Fission* , 2007, Journal of Biological Chemistry.
[43] P. Staeheli,et al. The X Protein of Borna Disease Virus Serves Essential Functions in the Viral Multiplication Cycle , 2007, Journal of Virology.
[44] S. Przedborski,et al. Protocol for the MPTP mouse model of Parkinson's disease , 2007, Nature Protocols.
[45] J. Milbrandt,et al. Stimulation of Nicotinamide Adenine Dinucleotide Biosynthetic Pathways Delays Axonal Degeneration after Axotomy , 2006, The Journal of Neuroscience.
[46] D. Chan. Mitochondria: Dynamic Organelles in Disease, Aging, and Development , 2006, Cell.
[47] R. G. Thorne,et al. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration , 2004, Neuroscience.
[48] T. Wolff,et al. The X protein of Borna disease virus regulates viral polymerase activity through interaction with the P protein. , 2004, The Journal of general virology.
[49] E. Perret,et al. Persistent, non‐cytolytic infection of neurons by Borna disease virus interferes with ERK 1/2 signaling and abrogates BDNF‐induced synaptogenesis , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[50] S. Münter,et al. Borna Disease Virus Glycoprotein Is Required for Viral Dissemination in Neurons , 2003, Journal of Virology.
[51] Jia Luo,et al. Subthalamic GAD Gene Therapy in a Parkinson's Disease Rat Model , 2002, Science.
[52] John T. Finn,et al. Axonal Self-Destruction and Neurodegeneration , 2002, Science.
[53] K. Ikuta,et al. Molecular and cellular biology of Borna disease virus infection. , 2002, Microbes and infection.
[54] T. Sherer,et al. Complex I and Parkinson's Disease , 2001, IUBMB life.
[55] D. German,et al. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[56] M. Herkenham,et al. Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: An in vivo autoradiographic study , 1991, Neuroscience.
[57] W. Nicklas,et al. IV. MPTP, MPP+ and mitochondrial function , 1987 .
[58] R. Prediger,et al. Evaluation of Nigrostriatal Neurodegeneration and Neuroinflammation Following Repeated Intranasal 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Administration in Mice, an Experimental Model of Parkinson’s Disease , 2013, Neurotoxicity Research.
[59] M. Lafon. Evasive strategies in rabies virus infection. , 2011, Advances in virus research.
[60] R. Abagyan,et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. , 2007, Science.
[61] R. Fujinami,et al. Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial? , 2007, The American journal of pathology.
[62] W. Nicklas,et al. MPTP, MPP+ and mitochondrial function. , 1987, Life sciences.